4.6 Article

Single-cell transcriptomic identified HIF1A as a target for attenuating acute rejection after heart transplantation

Journal

BASIC RESEARCH IN CARDIOLOGY
Volume 116, Issue 1, Pages -

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00395-021-00904-5

Keywords

Heart transplantation; Acute rejection; HIF1A; Immune metabolism

Funding

  1. National Natural Science Fund for Distinguished Young Scholars of China [82125004]
  2. National Natural Science Fund for General Program of China [81670376]

Ask authors/readers for more resources

Acute rejection (AR) is a significant contributor to graft failure post-heart transplantation, and the regulation of immune metabolism, particularly the increased glucose metabolism of cardiac macrophages in AR patients, has become a new focus for immunosuppressive drug development. Through single-cell RNA sequencing, it was found that during AR, cardiac resident macrophages were replaced by monocytes and proinflammatory macrophages, which exhibited higher antigen presentation and inflammatory recruitment capabilities, as well as glycolysis. The increase in glycolysis in monocytes/macrophages was primarily regulated by HIF1A, and inhibition of HIF1A could reduce inflammatory cells infiltration in AR.
Acute rejection (AR) is an important contributor to graft failure, which remains a leading cause of death after heart transplantation (HTX). The regulation of immune metabolism has become a new hotspot in the development of immunosuppressive drugs. In this study, Increased glucose metabolism of cardiac macrophages was found in patients with AR. To find new therapeutic targets of immune metabolism regulation for AR, CD45(+) immune cells extracted from murine isografts, allografts, and untransplanted donor hearts were explored by single-cell RNA sequencing. Total 20 immune cell subtypes were identified among 46,040 cells. The function of immune cells in AR were illustrated simultaneously. Cardiac resident macrophages were substantially replaced by monocytes and proinflammatory macrophages during AR. Monocytes/macrophages in AR allograft were more active in antigen presentation and inflammatory recruitment ability, and glycolysis. Based on transcription factor regulation analysis, we found that the increase of glycolysis in monocytes/macrophages was mainly regulated by HIF1A. Inhibition of HIF1A could alleviate inflammatory cells infiltration in AR. To find out the effect of HIF1A on AR, CD45(+) immune cells extracted from allografts after HIF1A inhibitor treatment were explored by single-cell RNA sequencing. HIF1A inhibitor could reduce the antigen presenting ability and pro-inflammatory ability of macrophages, and reduce the infiltration of Cd4+ and Cd8a+ T cells in AR. The expression of Hif1 alpha in AR monocytes/macrophages was regulated by pyruvate kinase 2. Higher expression of HIF1A in macrophages was also detected in human hearts with AR. These indicated HIF1A may serve as a potential target for attenuating AR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available